Nature Communications published the study.
Here are five observations:
1. Researchers led by Munitta Muthana, PhD, found that MRI scanners can also guide “tumor busting therapies” to certain areas in patients’ bodies.
2. Cells injected with paramagnetic iron oxide nanoparticles receive non-invasive guidance from MRI scanners to find primary and secondary tumor sites in a body.
3. With this efficient treatment, drug doses may be decreased.
4. Prior to this study, scientists were struggling with the targeting portion of cell-based therapy in tissues.
5. In this study, researchers tested their theories on mice with cells carrying SPIOs and the oncolytic virus. The mice demonstrated an 800 percent increase in the therapy effects.
Recent articles:
Managing denials in the ASC setting
Tenet shares fall 0.7%, SCA appoints new director & more — 4 key notes on ASC companies
Data stream network PubNub now HIPAA compliant: 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.